Abstract | BACKGROUND: METHODS: Thirty systemically healthy patients with ≥1 paired contralateral interproximal intrabony defect ≥4 mm deep along with an interproximal probing depth ≥6 mm and clinical attachment level ≥4 mm were randomized into two groups. Group 1 (G1) consisted of sites treated with open flap debridement followed by placement of DOX blended with β-TCP (DOX-β-TCP), whereas group 2 (G2) sites were treated with flap surgery followed by the placement of DOX blended with β-TCP after EDTA etching of the exposed root surfaces (DOX-β-TCP + EDTA). Samples of gingival crevicular fluid (GCF) were obtained 1, 3, 7, 14, and 21 days after surgery. Quantitative measurements of DOX were taken with high-performance liquid chromatography. Clinical evaluation and follow-up for 6 months were performed. RESULTS: At 21 days, the DOX-β-TCP + EDTA-treated group showed a 194.7 µg/mL value. The DOX-β-TCP + EDTA-treated group retained more DOX during the periods of 3, 7, 10, 14, and 21 days than the DOX-β-TCP-treated group. Six months after therapy, DOX-β-TCP + EDTA-treated sites showed more significant clinical improvements compared to DOX-β-TCP-treated sites (P ≤ 0.05). CONCLUSIONS:
EDTA root surface etching enhances DOX availability in the GCF following its release from β-TCP as a drug carrier.
|
Authors | Ahmed Y Gamal, Radi M Kumper, Abd El Reheem R Al Gendy |
Journal | Journal of periodontology
(J Periodontol)
Vol. 84
Issue 7
Pg. 924-33
(Jul 2013)
ISSN: 1943-3670 [Electronic] United States |
PMID | 23003915
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biocompatible Materials
- Calcium Phosphates
- Drug Carriers
- Matrix Metalloproteinase Inhibitors
- beta-tricalcium phosphate
- Edetic Acid
- Doxycycline
|
Topics |
- Acid Etching, Dental
(methods)
- Adult
- Alveolar Bone Loss
(surgery)
- Biocompatible Materials
(chemistry)
- Calcium Phosphates
(chemistry)
- Chromatography, High Pressure Liquid
- Chronic Periodontitis
(surgery)
- Debridement
- Doxycycline
(administration & dosage, analysis, pharmacokinetics)
- Drug Carriers
- Edetic Acid
(therapeutic use)
- Female
- Follow-Up Studies
- Gingival Crevicular Fluid
(chemistry)
- Humans
- Male
- Matrix Metalloproteinase Inhibitors
(administration & dosage, analysis, pharmacokinetics)
- Middle Aged
- Periodontal Attachment Loss
(surgery)
- Periodontal Index
- Periodontal Pocket
(surgery)
- Single-Blind Method
- Surgical Flaps
(surgery)
- Tooth Root
(drug effects)
- Treatment Outcome
|